Video
Immuno-Oncology | Video | Cardiovascular toxicities in immune checkpoint inhibitors-treated patients - ESMO 2024
This video highlights the findings from our joint real-world study on immune checkpoint inhibitors, revealing a higher incidence of cardiovascular events in patients than reported in clinical trials.
Immuno-Oncology
These insights are a game-changer for physicians, emphasizing the need to integrate real-world data with randomized clinical trial data to capture the full scope of patient outcomes.
Thank you Medimix and Danielle Delombaerde (AZ Maria Middelares).
These insights are a game-changer for physicians, emphasizing the need to integrate real-world data with randomized clinical trial data to capture the full scope of patient outcomes.
Thank you Medimix and Danielle Delombaerde (AZ Maria Middelares).
